Previous close | 13.70 |
Open | 13.70 |
Bid | 13.10 |
Ask | 15.40 |
Strike | 300.00 |
Expiry date | 2024-11-15 |
Day's range | 13.70 - 13.70 |
Contract range | N/A |
Volume | |
Open interest | 4 |
United Therapeutics Corp, a biotechnology firm, focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Over the past year, Christopher Causey has engaged in multiple transactions, selling a total of 12,640 shares and purchasing none. Shares of United Therapeutics Corp were priced at $304.18 on the day of the sale.
Director Judy Olian sold 1,700 shares of United Therapeutics Corp (NASDAQ:UTHR) on June 17, 2024, as reported in a recent SEC Filing.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.